Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 12;15(1):44.
doi: 10.1186/s13578-025-01382-1.

Special correlation between diet and MASLD: positive or negative?

Affiliations
Review

Special correlation between diet and MASLD: positive or negative?

Jia Liu et al. Cell Biosci. .

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic and systemic metabolic liver disease characterized by the presence of hepatic steatosis and at least one cardiometabolic risk factor (CMRF). The pathogenesis of MASLD involves multiple mechanisms, including lipid metabolism disorders, insulin resistance, inflammatory responses, and the hepato-intestinal axis of metabolic dysfunction. Among these factors, diet serves as both an inducement and a potential remedy in the disease's development. Notably, a high-lipid diet exacerbates fat accumulation, oxidative stress, and inflammatory responses, thereby promoting the progression of MASLD. Consequently, dietary induction models have become vital tools for studying the pathological mechanisms of MASLD, providing a foundation for identifying potential therapeutic targets. Additionally, we summarize the therapeutic effects of dietary optimization on MASLD and elucidate the role of specific dietary components in regulating the hepato-intestinal axis, lipid metabolism, and inhibiting inflammatory responses. In conclusion, studies utilizing animal models of MASLD offer significant insights into dietary therapy, particularly concerning the regulation of lipid metabolism-related and hepatoenteric axis-related signaling pathways as well as the beneficial mechanism of probiotics in hepatoenteric regulation. By understanding the specific mechanisms by which different dietary patterns affect MASLD, we can assess the clinical applicability of current dietary strategies and provide new directions for research and treatment aimed at disease modification.

Keywords: Curative strategy; Dietary models; Dietary therapy; Hepato-intestinal axis; MASLD; Pathological mechanism.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors have declared that no competing interest exists.

Figures

Fig. 1
Fig. 1
The pathological mechanisms of MASLD induced by a high-fat diet, including fat accumulation, mitochondrial dysfunction, inflammation, and hepato-intestinal axis disorders. Key pathways (AMPK, PPARs, SREBPs) are highlighted for their roles in regulating lipid metabolism, mitochondrial function, and inflammatory responses
Fig. 2
Fig. 2
How dietary intake probiotics influences MASLD. A high-sugar, processed diet disrupts gut balance, promoting oxidative stress and MASLD. In contrast, dietary fiber and supplements (Akkermansia, Prohep, oat beta-glucan) restore gut balance, reduce inflammation, enhance fatty acid oxidation, and alleviate MASLD progression

Similar articles

Cited by

References

    1. Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691–702. - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–86. - PMC - PubMed
    1. Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238. - PMC - PubMed
    1. Scoditti E, Sabatini S, Carli F, Gastaldelli A. Hepatic glucose metabolism in the steatotic liver. Nat Rev Gastroenterol Hepatol. 2024;21(5):319–34. - PubMed
    1. Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis. 2024;23(1):117. - PMC - PubMed

LinkOut - more resources